Surgical Oncology 1994; 3: 187-l 92
The extent and number of metastatic lymph nodes limit the efficacy of lymphadenectomy in patients with oesophageal carcinoma K. YANO, T. OKAMURA, Y. YOSHIDA, T. EZAKI AND K. YASUMOTO The Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
The extent
and number of metastatic
carcinoma
involving
more than
efficacy of lymphadenectomy.
lymph nodes in 52 patients
one lymph
node were
analysed
with oesophageal to determine
the
The patients were divided into two groups according to
the number of metastatic lymph nodes, group A: l-4 nodes (34 cases) and group B: 5 or more nodes (18 cases). The survival of all patients in group A was statistically better than that of the patients in group B (P=O.O2). In cases where metastatic nodes were restricted
to one region. the survival of patients
in group A was significantly
better
than that of patients in group B (P=O.O08). By contrast, in cases where metastatic nodes extended to two or more regions, there was no difference between the groups. The present study suggests that lymphadenectomy is effective only for patients with l-4 metastatic nodes that are restricted to a single region. Lymphadenectomy is less efficacious in cases with five or more metastatic nodes, even when the nodes are restricted to one region, and is similarly ineffective in cases with metastatic nodes extending to two or more regions, regardless of the number of positive nodes. Surgical Oncology 1894; 3: 187-192. Keywords:
oesophageal carcinoma, metastatic lymph nodes.
INTRODUCTION
been conclusive. the
Although
aggressive
surgical
treatment
number of new adjuvant therapies mented
[I, 21, the prognosis
phageal carcinoma rates
as
between
reported
most
adjacent
was
tissue
and
of operation
tomy
concomitant
However,
world’s
explained
regional
with
been performed the effiacy
literature
Environmental
lymph
Extended
oesophageal
MATERIALS
of
involve nodes
l-1,
with
and number
of
special
of metastatic
Second
METHODS
metastasis
out of a total of 120 patients with primary
lymphadenec-
oesophageal
resection
resection in the Department
has
has not
Department
Yahatanishi-ku,
carcinoma,
Hospital of Occupational Japan,
of
University of Occupational and Iseigaoka,
AND
This study was based on 52 cases with lymph node
the
at the
to improve survival [8, 91.
Dr Koichi Yano, Health,
prognosis
by the finding
of lymphadenectomy
Surgery, School of Medicine,
to the extent
and
carcinoma
are
went Correspondence:
features
oesophageal
lymph nodes.
of patients with oeso-
carcinomas
[5-71.
with
reference
have been imple-
[3, 41. The poor prognosis
partly
patients
a
poor. Five year survival
the
oesophageal
time
therefore
in
8 and 20%
such patients that
remains
and
In the present study, we assessed
clinicopathological
from either
who
of Surgery II, University
1980 to 1992. The 52 patients total
oesophagectomy
gastrectomy
through
laparotomy.
Thirty-four
intra-abdomen), 187
surgical
and Environmental
right
and
18
underwent
(cervical, cases
Health, under-
or oesophago-
thoracotomy
cases
regional lymphadenectomies
Kita-
kyushu, Japan 807.
underwent
and three
intrathoracic,
underwent
two
K. Yano
188
regional
lymphadenectomies
thoracic,
intrathoracic
patients
received
operative cally
as having
oesophagus node.
curative
treatment
Dissected
resection
with
lymph
oesophageal
were
cervical
hiatus)
region,
celiac
according
to the
general
for
no pre-
Survival
curves
Esophageal
and axis,
test was
lymph
survival
Ilcx, Apple were
method.
used for curves.
The
Inc.).
by
generalized
Wilcoxon
comparison
comparisons
the of the
between
on actual patient numbers
using the x2-test. A P value
intrathoracic
Computer,
calculated
statistical
Statistical
groups were performed
into deep,
CO.05 was considered
significant.
trunk to
intra-abdominal
common
hepatic),
of the
Japanese
rule
Kaplan-Meier
of the
divided
(superficial,
supraclavicular),
(epigastric Society
(Macintosh
histologi-
(from the area around the brachiocephalic the
computer
cell carcinoma
nodes
Cancer Staging. All data were entered into a micro-
intraThe 52
more than one metastatic
three groups as follows; para-oesophageal,
and
and were diagnosed
squamous
with
(cervical
and intra-abdomen).
et al.
Diseases
[IO].
RESULTS
The total
The clinicopathological
features of groups A and B
number of dissected lymph nodes over the 52 cases
are summarized
was 1771. The mean number of dissected lymph nodes per case was 34.1. The number of cases
of 44 men and 8 women ranging in age from 42 to 80 years. The mean age was 62.2 years. There were
according to the number of metastatic lymph nodes
no significant
is shown in Fig. 1. The maximum
sex, tumour
number of meta-
in Table 1. The 52 cases consisted
differences location,
between
tumour
groups
static lymph nodes in one case was 29. The average number of metastatic lymph nodes per case was
features. However, there were statistically
5.00. The 52 patients were divided
tumour
differences
into two groups
in T classification
significant
(the depth of primary
(P=
penetration)
in age,
size, or histological
0.008)
and
stage
regardless of the region of metastatic lymph nodes; group A includes cases with l-4 metastatic lymph
(P=O.O19). The extent of metastatic lymph nodes in groups A and B is shown in Table 2. In both groups, intrathoracic and intra-abdominal lymph nodes were
nodes, and group B includes cases with five or more
the most frequent
metastatic
cases in group A, 21 cases (61.8%) had metastatic
according to the number of metastatic lymph nodes,
nodes. There are 34 cases in group A,
and 18 cases in group B. All of the resected tumours were post-surgically staged by the TNM classification system of the American Joint Committee for
sites of metastasis.
nodes restricted to one region, while 13 (38.2%) had nodes in two or more regions. Of the 18 cases in group B, however, only 6 (33.3%) demonstrated
Figure 1. The number according
. I . 2’3‘4.5-6-7
8 Number of metastatic
9 lymph
Of the 34
II nodes
13
20
29
lymph
nodes.
metastatic cases.
to the number *Average
lymph
of cases of metastatic value of
nodes for all 52
Metastatic
lymph nodes of oesophageal
Table 1. Clinicopathological features of group A and group B
189
carcinoma
Group A n
P-value*
Group B VW
n
(%I
29
(85.3)
15
5
(14.7)
3
(83.3) (16.7)
NS
(11.1) (61.1) (27.7)
NS
(11.1) (22.2) (55.6) (11.1)
NS
Sex male
female Age <50 50-70 705
4
(11.8)
2
25
(73.5)
11
5
(14.7)
5
3
(8.8)
2
2
4
22
(5.9) (64.7)
10
7
(20.6)
2
<5
10
(29.4)
2
5-10
22
(64.7)
15
(11.1) (83.3)
2
(5.9)
1
(5.6)
well
11
(32.3)
2
moderately
14
(41.2)
12
9
(26.5)
4
(11.1) (66.7) (22.2)
TO
7
(20.6)
2
(11.1)
Tl
9
(26.5)
1
T2
10
(29.4)
2
(5.6) (11.1)
T3
8
(23.5)
13
(72.2)
118
17
(50.0)
3
(16.7)
Ill
17
(50.0)
15
(83.3)
Total
34
Tumour location cervical upper middle lower Tumour size (cm)
105 Histological
NS
differentiation
poorly
NS
Primary tumour
P = 0.008
Stage
P=O.O19
18
*P value based on x*-test. NS: not significant.
nodal metastases (66.6%)
had
regions
restricted
metastatic
(P= 0.036).
12
The survival of patients in group B was significantly
more
lower than that of the patients in group A (P=O.O2).
to one region while
nodes
The extent
in groups A and B according
in two
or
of metastatic to tumour
nodes
location
is
The
survival
lymph
curves
shown in Table 3. The tumours in the middle portion
and B are shown
showed
with
a broader distribution
stases compared There
were
of lymph node meta-
with tumours in the other portions.
no statistical
differences
between
the
two groups in this respect. are shown three
in Fig. 2. One patient
patients
diseases
were
in group excluded
restricted
B who
in group A and died
from
other
from the survival analysis.
patients
with
curves
of
metastatic
to one region in groups A
in Fig. 3. The survival of patients
nodes
in group A was significantly
higher than that in group B (P=O.O06). extending
The survival curves of patients in groups A and B
of
nodes restricted
patients
with
metastatic
The survival lymph
are shown in Fig. 4. There was no significant ence
between
survival.
nodes
to two or more regions in groups A and B the
two
groups
with
differ-
respect
to
190
K. Yano et al.
Table 2. Extent of metastatic
lymph
Location
nodes
of metastatic
lymph
nodes
in groups
A and B Group
A
Group n (%)
n (%) One region
B
n (%)
21 (61.8)*
n (%)
6 (33.3)*
cervical
4 (11.8)
2 (11.1)
intrathoracic
8 (23.5)
4 (22.2)
intra-abdominal
9 (26.5)
0 (0.0)
Two regions cervical
12 (35.3)
8 (44.4)
+ intrathoracic
intrathoracic
+ intra-abdominal
Three regions cervical
0 (0.0)
2 (11.1)
12 (35.3)
6 (33.3)
1 (2.9)
+ intrathoracic
4 (22.2)
+ intra-abdominal
1 (2.9)
Total
4 (22.2)
34 (100)
18 (100)
*P= 0.036.
Table 3. Comparison Tumour
of the extent Metastatic
of lymphatic
lymph
metastases
between
groups
A and B according
node location
Number
to tumour
location
of cases
location Total
Group A
Group
n
n
n
3
2
lntrathoracic
1
2
Cervical
+ intrathoracic
1
1
Cervical
+ intrathoracic
0
1
1
0
Cervical
B
5 Cervical 6
Upper
+ intra-abdominal
32
Middle Cervical lntrathoracic Intra-abdominal Cervical + intrathoracic lntrathoracic Cervical
+ intra-abdominal
+ intrathoracic
+ intra-abdominal
Lower lntrathoracic Intra-abdominal lntrathoracic + intra-abdominal
long term
DISCUSSION There number
have
been
studies
of lymph node metastases
oesophageal
carcinoma
nodal involvement the depth positive
a few
[I l-l
with
the
positive
nodes
in patients with
positive
examining
31. The frequency
has been closely correlated
of tumour
invasion,
of with
and the number
nodes has been examined
results [II].
patients
of
with respect to
16.3%
nodes and
one
or
5
0
1
2
Five year two
in the
abdomen
in the thorax
14.3%,
survival
positive
alone,
alone,
respectively,
rates of
nodes, were
while
with
or
with
14.5%,
nearly
all
patients with more than three positive nodes or with positive nodes in both the thorax and abdomen due to recurrence
within
three
died
years of operation
Metastatic
lymph nodes of oesophageal
Figure 2. Survival curves in patients with 1-4 metastatic nodes (group A) and five or more metastatic nodes (group 6). There was a significant difference between the two groups (P=O.O2).
191
carcinoma
1
I
I
I
12
24
36
48
I 60
Months after operation
P - 0.006
Figure 3. Survival curves of groups A and 6 in patients with metastatic lymph nodes restricted to one region. There was a statistically significant difference between the two groups (P=O.O06).
[12]. It has also been reported
0
12
24
that patients with six
[13]. The above studies examined
the metastatic
and did not perform
only the correla-
nodes with
prognosis
survival analysis based on the
number of positive nodes according metastatic
to the extent of
lymph nodes. Similar to previous studies,
the present study found that in many cases with five or
more
penetrated the
metastatic
nodes,
the adventitia
metastatic
nodes
regions. We have now determined patients with l-4
metastatic
the
tumour
of the oesophagus,
extended
60
tally greater than that of patients with five or more metastatic
of positive
46
Months after operation
or more positive nodes have a very poor prognosis tion of numbers
36
to two
or
whom
the positive nodes extended
static
nodes.
The
lymphadenectomy resection
and
lymph nodes is statisti-
are restricted
regions is poor regardless
static
that the survival of
nodes
to one region.
We have also found that the prognosis of patients in
had more
lymph nodes, but only in cases in which
present
nodes
Lymphadenectomy
may
metastatic
or more
with
of meta-
suggests
to a single
not be effective
when those nodes are restricted
lymph
that
oesophageal
only in cases with l-4 restricted
with
five
study
concomitant
is warranted
lymph
to two or more
of the number
metaregion.
in cases
nodes,
even
to one region and
K. Yano et al.
Group 8 (n 2 9)
Group
A (II:
13)
Figure
4. Survival
and B in patients 0’
lymph
t
I
I
12
24
I
Months after
46
to two or more regions. Therefore,
order to effect
a longer
metastatic
60
difference
after
nodes in
resection
of groups
A
metastatic
extending
to two or
No significant
was observed
in survival
the two groups.
for carcinoma
of the oesophagus.
Br J
Surg 1987; 74: 165-8.
post-
7. Galandiuk Cancer
the latter two
in
nodes
more regions. between
should be considered survival
I
operation
with
therapy
of
36
in cases
adjuvant
number
I
extending operative
any
I
curves with
S, Hermann
of esophagus:
RE, Gassman
JJ, Cosgrove
the Cleveland
clinic experience.
DM.
Ann Surg 1986; 203: 101-8.
groups.
8. Akiyama
H,
Udagawa
Tsurumaru
HY, Suzuki
carcinoma
M,
Watanabe
G,
M. Development
of the esophagus.
Ono
Y,
of surgery
Am J Surg 1984;
for 147:
9-16. 9. Mansour
REFERENCES
KA,
surgery
Downey
without
RS.
preoperative
Esophageal adjuvant
carcinoma:
chemotherapy.
Ann Thorac Surg 1989; 48: 201-5. 1. Naunheim
KS, Petruska
chemotherapy
and
carcinoma.
J
P, Roy TS, era/.
radiotherapy
Thorac
for
Cardiovasc
Surg
Preoperative
10. Japanese
oesophageal
lines
1992;
103:
Kanehara
SJ, Stewart
result
JR, Sawyers
with
neoadjuvant
oesophageal
carcinoma.
JL,
et a/. Preliminary
therapy Ann
and
resection
Thorac Surg 1993;
11
for 56:
282-7. 3. Wang
LS, Hsiung
M, Chein KU. Gastric
carcinoma
of oesophagus:
substitution an analysis
for
4. Skinner
DB.
esophagus
En
bloc
and cardia.
resection
for
metastasis
5. Akiyama
abstract).
of
H,
Tsurumaru
of surgical
oesophagus.
Kawamura for
T,
carcinoma
Ono
Y.
of the
van
M, Obertop
Andel
JG, van
H, Mud Houten
thoracic
T, Ando qualitative
edn.
on
Tokyo:
of
N, Kawahara
H, Abe
analysis
the
carcinoma
on
of
the
0.
lymph
esophagus
J Jpn Surg Sot 1986; 86: 424-34. of the patients
esophagus,
of metastatic (English
S, Shimazu esophageal
tion in three tionship
Ann Surg 1981; 194: 438-46.
Schattenkerk WMH,
M,
treatment
8th
Guide
Studies
with
with
special
lymph
nodes
abstract).
carcinoma
of
reference
to the
and
meta-
their
J Jpn Surg Sot 1988;
68: 413-21. 13. Natsugoe
Principles
Diseases.
Pathological
Esophagus,
N. Prognosis
number
neoplasms
and
static portions
85: 59-71.
boom
node
Esophageal and
Co., 1992.
the thoracic
J Thorac Cardiovasc Surg 1983;
the
H, Kakegawa
Quantitative
12. Omori
for
Clinical
of
of
368 cases. Ann Thorac Surg 1992; 53: 289-94.
6. Eeftinck
Fujita
(English
resectable
the
Carcinoma
887-95. 2. Hoff
Society
for
HJ, EijkenH. Survival
Gastroenterol
after
areas. With special
between
metastatic
H, Baba M, et al. Recurrence cancer
lymph
lymph reference
recurrence nodes
and
(English
Surg 1991; 24: 2888-93.
node
of
dissec-
to the relanumber
abstract).
of Jpn
J